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AbstrAct
Introduction ‘Standardised Endpoints for Perioperative 
Medicine’ (StEP) is an international collaboration 
undertaking development of consensus-based consistent 
definitions for endpoints in perioperative clinical 
trials. Inconsistency in endpoint definitions can make 
interpretation of trial results more difficult, especially 
if conflicting evidence is present. Furthermore, this 
inconsistency impedes evidence synthesis and meta-
analyses. The goals of StEP are to harmonise definitions 
for clinically meaningful endpoints and specify standards 
for endpoint reporting in clinical trials. To help inform 
this endeavour, we aim to conduct a scoping review to 
systematically characterise the definitions of clinically 
important endpoints in the existing published literature on 
perioperative blood loss and transfusion.
Methods and analysis The scoping review will be 
conducted using the widely adopted framework developed 
by Arksey and O’Malley, with modifications from Levac. 
We refined our methods with guidance from research 
librarians as well as researchers and clinicians with 
content expertise. The electronic literature search will 
involve several databases including Medline, PubMed-
not-Medline and Embase. Our review has three objectives, 
namely to (1) identify definitions of significant blood 
loss and transfusion used in previously published large 
perioperative randomised trials; (2) identify previously 
developed consensus-based definitions for significant 
blood loss and transfusion in perioperative medicine and 
related fields; and (3) describe the association between 
different magnitudes of blood loss and transfusion with 
postoperative outcomes. The multistage review process 
for each question will involve two reviewers screening 
abstracts, reading full-text articles and performing data 
extraction. The abstracted data will be organised and 
subsequently analysed in an iterative process.
Ethics and dissemination This scoping review of 
the previously published literature does not require 
research ethics approval. The results will be used to 
inform a consensus-based process to develop definitions 
of clinically important perioperative blood loss and 
transfusion. The results of the scoping review will be 
published in a peer-reviewed scientific journal.
IntroductIon
Concerns about the heterogeneous and inad-
equate reporting of randomised controlled 
trials (RCT) have led to the development 
of consensus-based reporting standards, 
an example being the Consolidated Stan-
dards of Reporting Trials (CONSORT) 2010 
Consensus statement.1 Subsequent adop-
tion of CONSORT recommendations has 
been associated with improved clarity in the 
reporting of published trials.2 Nonetheless, 
there still remains considerable heterogeneity 
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Protocol
Strengths and limitations of this study
 ► This scoping review will use established research 
methodology, incorporate an electronic database 
search strategy developed by an experienced 
research librarian and benefit from the guidance of 
a multidisciplinary expert panel.
 ► The results of the scoping review will directly inform 
an international multidisciplinary programme to 
develop comprehensive and standardised endpoint 
definitions for perioperative clinical trials.
 ► Limitations include the exclusion of the grey literature 
and non-English papers. To minimise the impact of 
these limitations, we will consult content experts to 
ensure that relevant articles are not missed.
 ► While the review excludes articles published prior 
to 2005, this exclusion criterion will help focus the 
study on more contemporary evidence pertaining 
to clinically significant perioperative blood loss and 
transfusion.
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with respect to important aspects of RCT design, a key 
example being how endpoints are defined in indi-
vidual trials. Considerable variation in the definitions 
of important endpoints, either individual or composite, 
can make it difficult for readers to draw conclusions, 
especially when faced with studies that assessed similar 
interventions but had conflicting results. Such heteroge-
neity can also render evidence synthesis problematic and 
unreliable.3 4 Growing recognition of this problem has led 
to initiatives to better standardise endpoint definitions in 
clinical trials, a key example being the Core Outcomes 
Measures in Effectiveness Trials (COMET) Initiative.5
Significant blood loss and transfusion are clinically 
relevant and prognostically important events in periop-
erative care.6 They are often reported as primary efficacy, 
secondary efficacy or safety endpoints in RCTs of surgical 
patients. Nonetheless, even a cursory evaluation of the 
surgical or anaesthesiology literature reveals considerable 
between-trial heterogeneity with respect to the defini-
tions of clinically important blood loss and transfusion; 
the clinical relevance and prognostic importance of these 
definitions; and the extent to which detailed information 
on blood loss and transfusion is collected.7–11 In other 
fields of medicine, methodological attention has been 
paid towards standardising the definition of important 
blood loss and transfusion. For example, the Bleeding 
Academic Research Consortium (BARC) was established 
in 2010 to standardise endpoint reporting in cardiovas-
cular clinical trials.12
The ‘Standardised Endpoints for Perioperative Medi-
cine’ (StEP) initiative is an international multidisciplinary 
programme with an overarching goal of developing 
comprehensive and standardised endpoint definitions for 
straightforward, clinically sensible and valid application 
to clinical trials in perioperative medicine.13 The initiative 
will use methodology adapted from existing guideline 
task forces.14–16 It is composed of a multidisciplinary 
range of experts, who are themselves organised into 
several endpoint-specific subgroups. Each subgroup will 
use a consensus-building process (eg, Delphi or nominal 
group methods) to define standardised definitions for 
endpoints within specific domains, such as cardiovas-
cular or respiratory complications. The Blood Loss and 
Transfusion subgroup of StEP is composed of a range 
of content and methodology experts, including senior 
researchers with expertise in anaesthesiology, surgery, 
transfusion medicine, haematology, multicentre clinical 
trials and clinical epidemiology. The subgroup is tasked 
with developing standardised definitions for clinically 
significant blood loss or transfusion in the perioperative 
period. These definitions will be linked to recommen-
dations regarding data collection in RCTs, such as how 
perioperative blood loss and blood product transfusion 
should be measured.
To establish a baseline and inform the consensus-based 
development of these standardised endpoint definitions, 
a systematic and thorough evaluation of the existing liter-
ature is critical. A scoping review is an ideal approach 
for achieving this objective. Specifically, scoping reviews 
are suited for mapping broad areas of the literature to 
gain an understanding of the extent, range and nature 
of research activity within a field.17–23 As a prelude to 
developing consensus-based definitions for clinically 
significant perioperative blood loss and transfusion, we 
therefore plan to conduct a scoping review to answer 
three broad relevant questions:
1. What definitions for significant blood loss or transfusion 
have been previously successfully implemented in 
perioperative RCTs with reasonably large numbers of 
trial participants? Prior successful use in larger RCTs 
serves as supporting evidence showing the feasibility 
and practicability of implementing these endpoint 
definitions.
2. What consensus-based definitions of significant blood 
loss or transfusion have been previously developed 
for application in perioperative medicine and related 
fields?
3. What is the association of different magnitudes of 
blood loss and transfusion with clinically important 
patient outcomes?
Methods and analysIs
The scope of StEP encompasses perioperative medicine 
in adults, with perioperative medicine being defined 
as all aspects of anaesthesiology and perioperative care 
other than the surgical technique itself. Obstetrics, pain 
and critical care are included in contexts where they 
overlap with anaesthesiology and surgery.14 The aim of 
StEP is to harmonise standardised endpoints that can be 
used in clinical trials studying a range of interventions. 
With respect to the scope of work for the blood loss and 
transfusion subgroup of the StEP initiative, all endpoints 
within this domain that relate to blood loss and transfu-
sion are of interest.
A thorough review of the existing literature is an 
important prerequisite for informing development of 
these consensus-based definitions. The overarching aim 
of this review is to answer the question ‘What endpoints are 
currently used to measure blood loss and transfusion in the recent 
perioperative literature?’ In conducting this scoping review, 
we will employ the widely used Arksey and O’Malley 
framework, with some modifications from Levac.21–23
In summary, all potentially relevant studies will be iden-
tified using a comprehensive electronic database search 
strategy that was developed with guidance from an expe-
rienced research librarian (ME) with expertise in scoping 
reviews. This list of relevant studies will be supplemented 
as needed by consulting content experts in the Blood 
Loss and Transfusion subgroup of StEP. Identification of 
the final pool of relevant studies will then be undertaken 
using a minimum two-step selection process involving 
two reviewers. Data from the final included studies will 
be collected and charted, and subsequently collated 
and summarised. The results of the scoping review will 
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Box 1 Research questions identified for scoping review
1. What endpoint definitions for significant blood loss and 
transfusion are currently used in perioperative randomised trials?
Population: adults (≥18 years) participating in a randomised controlled 
trial with an overall study sample size ≥500 participants. These 
patients must have undergone surgical procedures, anaesthetic 
procedures, minimally invasive procedures or interventions offered 
as part of an admission to a surgical intensive care unit. To help 
ensure that the number of potentially relevant trials is maintained in 
a reasonable range, we will exclude trials focused on interventional 
cardiology and interventional radiology procedures.
Intervention/comparators: any intervention that justifies the inclusion 
of blood loss or transfusion as a study endpoint.
Outcome: the primary or secondary endpoint of the study should be 
significant blood loss or blood product transfusion.
2. What are the existing consensus definitions for significant 
blood loss or transfusion in perioperative medicine and related 
fields?
Population: adults (≥18 years) undergoing surgical procedures, 
anaesthetic procedures, minimally invasive procedures or interventions 
offered as part of an admission to a surgical intensive care unit. 
Interventional cardiology and interventional radiology procedures will 
be considered.
Interventions or comparators: any intervention that justifies the use of 
blood loss or transfusion as a study endpoint.
Study content requirement: the study must report a consensus-
based definition for reporting blood loss or transfusion. Systematic 
reviews will be included to identify any cases where the authors who 
synthesised evidence adopted any established consensus definitions.
3. What elements of blood loss and transfusion are associated 
with clinically important patient outcomes?
Population: adults (≥18 years) included in a (prospective or 
retrospective) cohort study or randomised controlled trial. Relevant 
evidence synthesis, such as meta-analysis, can be included. These 
patients must have undergone a surgical procedure, anaesthetic, 
minimally invasive procedure or intervention offered as part of 
an admission to a surgical intensive care unit (most procedures 
conducted by interventional cardiology or interventional radiology will 
be excluded).
Exposure of interest: administration of blood products or blood loss.
Outcome: any short-term postoperative (ie, within 30 days or less after 
surgery) outcome including complications (eg, myocardial infarction, 
stroke and acute kidney injury), death and hospital length of stay.
be reported to the StEP Blood Loss and Transfusion 
subgroup. The details of each step are presented below.
stage 1: identifying the research questions
Our aims are to (1) provide an understanding of the 
current extent of the published literature in perioper-
ative medicine where blood loss and transfusion were 
reported as endpoints, (2) map the types of definitions 
used and (3) understand the extent to which elements 
of existing definitions of blood loss and transfusion are 
related to other patient outcomes. For this review, ‘trans-
fusion’ refers to transfusion of red blood cells, either in 
isolation or in combination with other blood components 
(eg, platelets and plasma). The details of the three ques-
tions are presented in box 1. With guidance of a research 
librarian, we iteratively refined our electronic database 
search strategy to identify potentially relevant studies. 
To further categorise the identified studies into manage-
able subdomains, we subdivided our overarching search 
question into three components, namely identification 
of definitions of significant blood loss and transfusion 
used in perioperative randomised trials of significant size, 
identification of previously published consensus-based 
definitions of significant blood loss and transfusion in 
perioperative medicine and related fields, and identifica-
tion of studies describing the dose-response association 
between different magnitudes of blood loss and transfu-
sion with important short-term postoperative outcomes 
(ie, within 30 days or less after surgery). We defined trials 
of significant size a priori as those recruiting 500 or more 
participants. This threshold was selected because it has 
face validity, impacted the feasibility of the conducting the 
review and confirmed the practicability of implementing 
these endpoint definitions in clinical trials. In developing 
harmonised definitions of clinically significant blood 
loss and transfusion, we do not plan to include literature 
focused on the association of blood loss or transfusion 
with intermediate or long-term outcomes (ie, more than 
30 days after surgery). Notably, perioperative blood loss 
and transfusion can plausibly have important interme-
diate and long-term effects on patients’ health; however, 
most perioperative randomised trials focus on measuring 
the effects of interventions on shorter term outcomes, 
typically within 30 days after surgery. Hence, the demon-
stration of a dose–response association between different 
magnitudes of blood loss and transfusion with short-term 
postoperative outcomes will help support the criterion 
validity of any endpoint definition recommended by the 
StEP Blood Loss and Transfusion subgroup.
stage 2: search strategy
Given the volume and extent of the literature addressing 
blood loss and transfusion in perioperative medicine, we 
will exclude the grey literature since it is highly likely that 
almost all relevant information is already captured by 
the indexed published literature. In addition, the litera-
ture search will be restricted to English-language articles 
published in a contemporary period, which is defined as 
2005 onwards.
eligibility criteria for studies
The prespecified inclusion and exclusion criteria are 
presented in table 1. These criteria were used to guide 
development of the electronic database search and help 
establish an initial abstract screening form.
databases
The electronic databases to be searched are Medline, 
Medline In-Process, Embase, and PubMed-NOT-Medline.
search strategy
The electronic search strategy was developed iteratively by 
a team of three authors (JB, ME and DNW) that included 
a research librarian. The primary search terms were 
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Table 1 Inclusion and exclusion criteria used to identify potentially relevant studies
Inclusion criteria Exclusion criteria
1. Published in the English language
2. Published in a peer-reviewed journal
3. Human subjects
4. Publication date from 2005 onwards
5. Limited to adults (≥18 years)
6. Research targeting patients undergoing surgery, anaesthetic 
procedures and minimally invasive interventions as well as 
patients who have been admitted to a postsurgical critical 
care unit
1. Journal articles that were not original research or system-
atic reviews (eg, case reports, case series, opinion pieces, 
commentaries or editorials)
focused on variations of blood loss and transfusion, with 
secondary search terms including various terms related to 
significant or clinically important bleeding. These terms 
were combined using Boolean operators with other terms 
to capture relevant fields (perioperative medicine and 
related fields), consensus-based endpoint definitions or 
postoperative outcomes. These search results were filtered 
to include English-language studies in adult humans from 
2005 onwards. In iterative steps, we evaluated 200–400 
abstracts identified by successive versions of this search 
strategy to determine if further refinement of the strategy 
was required. The final version of the search strategy is 
presented in the online supplementary appendix 1. Once 
the final search strategy is implemented, the results (after 
elimination of any duplicates) will be uploaded into Distill-
erSR (2016, Evidence Partners, Ottawa, Ontario, Canada) 
to facilitate further article screening and selection. This 
list of potentially relevant studies will be supplemented as 
needed by consulting content experts in the Blood Loss 
and Transfusion subgroup of StEP.
stage 3: study selection
Study screening and selection will involve a multistage 
process with at least two reviewers. For questions 2 and 3, 
two reviewers (JB and LV) will conduct screening of titles 
or abstracts and full-text review of selected articles. All 
disagreements will be resolved by discussion and, where 
necessary, involvement of a third reviewer (DNW). Due 
to the large volume of potentially relevant articles iden-
tified for question 1, a modified study selection process 
will take place. In the first step, a single reviewer (JB) 
will screen abstracts to identify any potentially relevant 
studies. To maximise sensitivity in this additional first 
step, any study with uncertain relevance will be retained 
for consideration in the next screening stage. The 
remaining steps in the screening and selection process 
will be identical to those employed for questions 2 and 
3. The full inclusion and exclusion criteria applied 
for each stage of study screening and evaluation are 
presented in table 2. A Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses (PRISMA) flow 
diagram will be used to report the conduct of this search 
strategy.24
stage 4: charting the data
An initial set of data categories to be abstracted are 
presented in table 2. These initial data categories were 
identified based on their relevance to the goals of the 
StEP initiative.14 Based on the types of interventions, 
outcomes and patient samples encountered in the 
abstract screening stages, these domains may be further 
refined. As with study selection, all data extraction will 
be performed by two reviewers (JB and LV). Their data 
extraction results will be compared, and any disagree-
ments will be resolved through discussion or involvement 
of a third reviewer (DNW). We do not plan to contact 
study authors to obtain any further information or data 
that were not published in peer-reviewed manuscripts.
stage 5: collating, summarising and reporting the results
Once data extraction is completed, we will organise the 
included studies into categories that are meaningful 
for the StEP subgroup. For question 1, we will group 
the published literature by the categories of endpoint 
definitions used in existing trials, attempting to identify 
how endpoints used in published perioperative trials are 
related to existing consensus-based definitions of signif-
icant blood loss or transfusion. For question 2, we will 
organise consensus-based statements and guidelines based 
on the interventions and patient subgroups to which they 
were designed for application. For question 3, studies will 
be organised broadly based on how blood loss or trans-
fusion were characterised (eg, presence of transfusion, 
changes in haemoglobin values and estimated surgical 
blood loss during the operation) and how these expo-
sures were associated with patient outcomes. We will look 
for themes in how various predictors consistently relate to 
patient outcomes.23 24 Interim reviews will be undertaken 
during the data processing to seek feedback from the StEP 
Blood Loss and Transfusion working group. Consultation 
with content experts in the working group will inform 
any required changes in the organisational structure 
used to classify the literature. Additionally, these content 
experts will help identify any relevant studies that were 
not initially identified in the electronic database search. 
Importantly, they will add insight into the relevance of 
the findings and which context the findings should be 
interpreted.21–24 The final results will be reported using 
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a framework similar to that used in prior scoping reviews 
applied to questions in critical care, anaesthesiology and 
health policy.17–24
ethIcs and dIsseMInatIon
As a scoping review of the previously published literature, 
this study does not require research ethics approval. The 
results of the scoping review will be presented at rele-
vant national and international conferences as well as 
published in a peer-reviewed scientific journal. As indi-
cated previously, we will use the results of this review 
to inform the StEP consensus-based process to develop 
definitions of clinically important perioperative blood 
loss and transfusion. The results of this consensus-based 
endpoint definition process will be published separately 
in a peer-reviewed scientific journal.
conclusIons
This protocol details the methodology for the conduct 
of a large comprehensive scoping review with the aim 
of informing the Blood Loss and Transfusion subgroup 
of StEP. This review will encompass a wide variety of 
research material, including observational studies, clin-
ical trials and evidence synthesis. The methodology is 
further strengthened by continual feedback from stake-
holders and content experts as well as early involvement 
of an experienced research librarian. As researchers 
and clinicians increasingly recognise the limitations of 
widely disparate endpoint definitions in clinical trials, we 
expect more collaborations to be formed within various 
fields to help standardise endpoint reporting. Scoping 
reviews, such as the one presented in this protocol, will 
be an integral part of the process to develop standardised, 
pragmatic and clinically relevant endpoint definitions for 
clinical trials.
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